Linköping University Hospital
Linköping, Sweden
NCT Number: NCT07100756
The aim of this study is to evaluate clinical effectiveness and cost-effectiveness after implementing a medically approved and commercially available AI support system for opportunistic vertebral fracture screening in CT examinations within an adapted fracture care pathway (integrated care process) in clinical routine. Data will be compared to historical data (same period the previous year).
The main question it aims to answer is: Does opportunistic AI-supported vertebral fracture screening in CT examinations integrated to a fracture care pathway increase the numbers of diagnosed vertebral fractures compared to usual care?
CT scans in the clinical routine care will be opportunistically screened for vertebral fractures by the AI for 4 months. All positive findings will be confirmed by a radiologist and triaged by the FLS (Fracture Liaison Service).
This study is active but is not currently recruiting participants.
Notify Me50 year and older
All sexes
Observational
Linköping, Sweden
Objective: This study aims to compare a 4-month period during which AI support was integrated into the clinical fracture pathway (AI-cohort) with a historical cohort from the same period one year earlier (control-cohort). The prevalence of vertebral fractures on CT scans is expected to remain constant during this period.
The two cohorts include:
Timeframe: Data from the AI-intervention period, spanning 4 months (20 October 2024-19 February 2025), will be analyzed. The same timeframe will be used for the historical cohort from the previous year (2023-2024).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-CT scans using spine-only protocol with exclusively skeletal queries
The AI (name: Flamingo from Image Biopsy Lab, IBL, Vienna, Austria) screens thoracic and abdominal CT scans for vertebral fractures.
Time frame: Within 3 months from CT scan
Numbers of ICD-coded vertebral fractures within 3 months from the CT scan.
Time frame: Within 2 months after the CT scan
Numbers of patients with vertebral fractures that are mentioned in the radiology report after the CT scan.
Time frame: Within 12 months after the CT scan
Numbers of patients screened with DXA (osteoporosis investigation) within 1 year after the CT scan.
Time frame: Within 12 months after the CT scan
Numbers of patients treated with antiosteoporotic drugs 1 year after CT scan.
Time frame: Two time frames: Within 12 months after the CT scan and long-term using a decision-analytic model to assess outcome in 10 years
Incremental cost per outcome compared to no AI guidance.
Time frame: Baseline
Performance (true positive, false positive, true negative and false negative) of AI detection of vertebral fractures compared to radiologist (ground truth).
Only in the cohort "AI screening aligned with FLS"
Time frame: Baseline
Numbers of vertebral fractures that are detected by AI and confirmed by radiologist in an opportunistic clinical setting. Only in the cohort "AI screening aligned with FLS".
Time frame: Baseline
Numbers of radiologist verified vertebral fractures that were new (not previously visualised), or worsened since previous CT (minimum 3 months old). Only in the cohort "AI screening aligned with FLS"
Time frame: Baseline
Numbers of old previously visualized vertebral fractures that were previously undiagnosed (ICD-code). Only in the cohort "AI screening aligned with FLS"
Time frame: Baseline
Numbers of patients with vertebral fracture that were untreated at the time of the CT scan. Only in the cohort "AI screening aligned with FLS".
Time frame: 1 month
Numbers of patients with vertebral fracture that needs further action according to the FLS. Only in the cohort "AI screening aligned with FLS".
University Hospital, Linkoeping
Other
Effectiveness of Implementation of Opportunistic AI-screening for Vertebral Fractures in Clinical Practice - the vertAIdo Project (Vertebral Fracture AI Detection for Better Osteoporosis Care)
Acronym: vertAIdo
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05283148
Anemia, Anemia, Hemolytic
Sacramento, California, United States
View Trial DetailsNCT06449742
Back Injuries, Bone Diseases
Milan, Italy
View Trial DetailsNCT07288684
Back Injuries, Bone Diseases
Waterloo, Ontario, Canada
View Trial DetailsNCT00638768
Back Injuries, Bone Diseases
Melbourne, Victoria, Australia
View Trial Details